Type
- Cancellation by sponsor (513)
- ARTG (460)
- Australian public assessment report (AusPar) (69)
- Prescription medicine registration (44)
- Section 14, TGO91 consent (21)
- Prescription medicine decision summary (19)
- Designation or determination (9)
- Cancellation or suspension (7)
- Prescription medicine evaluation (1)
Date
- 2026 (4)
- 2025 (38)
- 2024 (86)
- 2023 (73)
- 2022 (59)
- 2021 (124)
- 2020 (107)
- 2019 (98)
- 2018 (95)
- 2017 (73)
- 2016 (12)
- 2015 (22)
- 2014 (19)
- 2013 (9)
- 2012 (8)
- 2011 (14)
- 2010 (27)
- 2009 (13)
- 2008 (5)
- 2007 (11)
- 2006 (8)
- 2005 (4)
- 2004 (8)
- 2003 (3)
- 2002 (10)
- 2001 (6)
- 2000 (20)
- 1999 (9)
- 1998 (12)
- 1997 (16)
- 1996 (8)
- 1995 (3)
- 1994 (31)
- 1993 (17)
- 1992 (5)
- 1991 (86)
Sponsor content
1143 result(s) found, displaying 221 to 230
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ENBREL etanercept (rch) 50 mg solution for injection cartridge.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ENBREL etanercept (rch) 25 mg solution for injection cartridge.
-
Australian public assessment report (AusPar)New AusPAR for Comirnaty (tozinameran) for the prevention of COVID-19 in individuals 6 months of age and older.
-
Australian public assessment report (AusPar)AusPAR for COMIRNATY (tozinameran) for the prevention of COVID-19.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RUXIENCE Rituximab 500mg/ 50mL concentrated solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for RUXIENCE Rituximab 100mg/ 10mL concentrated solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABRILADA adalimumab 40 mg solution for injection pre-filled pen.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABRILADA adalimumab 40 mg solution for injection pre-filled syringe.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABRILADA adalimumab 40 mg solution for injection vial.
-
ARTGAustralian Register of Therapeutic Goods (ARTG) information for ABRILADA adalimumab 20 mg solution for injection pre-filled syringe.